Eric Harris, DO, hematologist/oncologist, Florida Cancer Specialists & Research Institute, gives Targeted Oncology an insiders perspective on the current state of community oncology in Florida and some ways the Florida Society of Clinical Oncology (FLASCO) aids in improving patient care by helping physicians.
Eric Harris, DO, hematologist/oncologist, Florida Cancer Specialists & Research Institute, gives Targeted OncologyTM an insiders perspective on the current state of community oncology in Florida and some ways the Florida Society of Clinical Oncology (FLASCO) aids in improving patient care by helping physicians.
The condition of community oncology in Florida affects patient access specifically. Harris states that because of this, particular communities cannot get support during cancer treatment, or have no access to care at all. In other cases, insurance companies may add obstacles that further the problem for both patients and physicians trying to treat them.
Cretostimogene Grenadenorepvec Shows High CR Rate in BCG-Unresponsive NMIBC
July 17th 2024Mark D. Tyson, II, MD, MPH, discussed treatment with cretostimogene grenadenorepvec in high-risk Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer with carcinoma in situ and data from the BOND-003 trial.
Read More